HARUNO Akihiro | Department of Phamacology, Yamanashi Medical University
スポンサーリンク
概要
関連著者
-
HARUNO Akihiro
Department of Phamacology, Yamanashi Medical University
-
Hashimoto Keitaro
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
HASHIMOTO Keitaro
Department of Phamacology, Yamanashi Medical University
-
Xue Yi
Department Of Pathology Yamanashi Medical University
-
Hirasawa Akira
Department Of Gynecology Keio University Hospital
-
HASHIMOTO Keitaro
Department of Pharmacology, Interdisciplinary Graduate School of Medicine and Engineering, Universit
-
Hirasawa A
Ajinomoto Co. Inc. Kawasaki Jpn
-
AWAJI Takeo
Department of Phamacology, Yamanashi Medical University
-
XUE Yixue
Department of Phamacology, Yamanashi Medical University
-
WU Zhenjiu
Department of Phamacology, Yamanashi Medical University
-
Hirasawa Akira
Department Of Biophysics And Biochemistry Graduate School Of Science The University Of Tokyo
-
Xue Y
Yamanashi Medical Univ. Yamanashi
-
Wu Zhenjiu
Department Of Phamacology Yamanashi Medical University
-
Awaji T
National Children's Medical Res. Center Tokyo Jpn
-
Awaji Takeo
Department Of Molecular Cell Pharmacology National Children 's Medical Research Center
-
Haruno A
Yamanashi Medical Univ. Yamanashi Jpn
-
Haruno Akihiro
Department Of Pharmacology Yamanashi Medical University
-
Sugiyama Atsushi
Department Of Pharmacology Yamanashi Medical University
-
Xue Yixue
Department Of Phamacology Yamanashi Medical University
-
Hashimoto K
Yamanashi Medical Univ. Yamanashi Jpn
-
Sugiyama Atsushi
Department Of Chemistry College Of Science Rikkyo University
-
Hashimoto Keitaro
Department of Pharmacology, Yamanashi Medical University
著作論文
- Effect of the New Class III Antiarrhythmic Drug MS-551 and d-Sotalol on Canine Coronary Ligation-Reperfusion Ventricular Arrhythmias
- Antiarrhythmic Effects of Bisaramil on Triggered Arrhythmias Produced by Intracoronary Injection of Digitalis and Adrenaline in the Dog
- Chronotropic, Inotropic, Dromotropic and Coronary Vasodilator Effects of Bisaramil, a New Class I Antiarrhythmic Drug, Assessed Using Canine Isolated, Blood-Perfused Heart Preparations